Stay updated with breaking news from Greg Molnar. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- SynerFuse released a two-year global patent search demonstrating that the 12-person Minnesota-based startup is a "Top 10" neuromodulation...
Share this article Share this article MINNEAPOLIS, March 4, 2021 /PRNewswire/ -- SynerFuse™, a developer of a novel implantable neurostimulator intended to treat chronic low-back pain without the use of addictive opioids, today announced a strategic development and manufacturing relationship with Cirtec Medical Corporation to support their current investigational and future commercial technology needs. The partnership is focused on the development of the NeuroFuse™ DRG therapy, which uniquely integrates spinal fusion and neuromodulation in order to attack the problem of chronic low-back...
Skip to main content Currently Reading Cirtec completes Device Master File (MAF) for their recent acquisition of the Nuvectra Algovita Spinal Cord Stimulation System PRWeb FacebookTwitterEmail MINNEAPOLIS (PRWEB) February 01, 2021 Cirtec Medical Corporation, a strategic outsourcing partner for complex medical devices including active implantables, minimally invasive devices and novel catheter-based delivery systems, today announced a sponsor-initiated withdrawal of the premarket approval (PMA) for the Nuvectra Algovita Spinal Cord Stimulation System. The System was an FDA and CE Mark approved...